Key result
Multi-chamber STE staging links to ~68% more periprocedural adverse events per stage in severe degenerative MR.
Why the study?
In asymptomatic severe primary MR, surgical referral based on two-dimensional echocardiography often identifies advanced myocardial injury, whereas speckle-tracking echocardiography (STE) may detect earlier, reversible dysfunction.
Does a multi-chamber STE-based staging system improve perioperative risk stratification in patients with severe degenerative mitral regurgitation undergoing surgery?
Cohort (n=300)
Yes
Does a multi-chamber STE-based staging system improve perioperative risk stratification in patients with severe degenerative mitral regurgitation undergoing surgery?
Odds Ratio: 1.68 (95% CI 1.24–2.32)
p-value: p=0.001
A novel multi-chamber speckle-tracking echocardiography staging system provides incremental prognostic information beyond conventional parameters, improving perioperative risk stratification in patients undergoing surgery for severe degenerative mitral regurgitation.
Strain staging may refine perioperative risk prediction in degenerative MR surgery; hypothesis-generating pending prospective validation.
Aims In asymptomatic patients with severe primary mitral regurgitation (MR), surgical referral is based on two–dimensional echocardiographic indices that often identify advanced myocardial injury. Speckle–tracking echocardiography (STE) may detect earlier, reversible dysfunction. This study evaluated whether a novel multi–chamber STE–based staging system of extra–valvular cardiac damage improves risk stratification in patients with severe degenerative MR undergoing surgery. Methods Retrospective multicenter cohort study of patients with degenerative MR undergoing surgery: derivation cohort (n = 208; mean age 64 ± 13 years; 59.7% men) and validation cohort (n = 92; mean age 63 ± 12 years; 53.3% men). Receiver operating characteristic curve analysis identified optimal strain cut–offs associated with adverse outcomes: left ventricular global longitudinal strain (LVGLS) ‹ 20%, peak atrial longitudinal strain (PALS) ‹ 25%, and right ventricular free–wall longitudinal strain (RVFWLS) ‹ 17%. Patients were classified into four stages: Stage 0, no damage; Stage 1, left atrial damage (PALS ‹ 25%); Stage 2, left ventricular damage (LVGLS ‹ 20%); Stage 3, right ventricular damage (RVFWLS ‹ 17%) (Figure 1). Results The STE–based staging system was independently associated with the composite of periprocedural adverse events (mortality, stroke, myocardial infarction, acute kidney injury, life–threatening bleeding or sepsis/wound infection requiring reintervention, complete atrioventricular block requiring pacemaker implantation): odds ratio 1.68 per stage increase (CI 1.24–2.32; p = 0.001) (Figure 2, 3). Predictive accuracy was higher compared with clinical and echocardiographic data, with consistent results in the validation cohort. Conclusions The multi–chamber STE staging system provides incremental prognostic information beyond conventional parameters, improving perioperative risk stratification.
No takes yet. Share an insight, caveat, or question.
Pasquini et al. (2026) conducted a cohort in Severe degenerative mitral regurgitation (n=300). Multi-chamber STE-based staging system was evaluated on Composite of periprocedural adverse events (mortality, stroke, myocardial infarction, acute kidney injury, life-threatening bleeding or sepsis/wound infection requiring reintervention, complete atrioventricular block requiring pacemaker implantation) (OR 1.68, 95% CI 1.24-2.32, p=0.001). A multi-chamber STE-based staging system was independently associated with periprocedural adverse events in severe degenerative MR (OR 1.68 per stage increase; 95% CI 1.24-2.32; p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: